Eskalith helps regulate mood for those who have Bipolar disorder. Avoid taking NSAIDs such as Advil, Motrin (ibuprofen) and Aleve (naproxen) as these may interact with Eskalith and cause you harm.

Eskalith Overview

Reviewed: November 10, 2014

Eskalith is a prescription medication used to treat manic episodes in people with bipolar disorder. It is also used as a maintenance medication to reduce these episodes in people with bipolar disorder. Eskalith belongs to a group of medications called antimanic agents. It works by decreasing abnormal activity in the brain.

Eskalith is available as capsules and is usually taken 3 to 4 times a day.

Common side effects of Eskalith include uncontrollable shaking in the hands, increased urination, thirst, and nausea. Eskalith can also cause dizziness. Do not drive or operate heavy machinery until you know how Eskalith affects you.

*Brand name Eskalith capsules are no longer available. Generic versions are made available by several manufacturers.

How was your experience with ?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking ?

What are you taking for?

Choose one
  • Other
  • Bipolar Disorder
  • Conduct Disorder
  • Depressive Disorder
  • Stress Disorders, Post-traumatic

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend to a friend?

Eskalith Cautionary Labels



Eskalith Drug Class

Eskalith is part of the drug class:

Eskalith FDA Warning



Lithium toxicity is closely related to serum lithium levels, and can occur at doses close to therapeutic levels. Facilities for prompt and accurate serum lithium determinations should be available before initiating therapy


All RxWiki content including health news, medication pages, and condition pages published prior to February 2023, was written and maintained by on-staff pharmacists. Please be advised that this content is no longer actively maintained and may now contain outdated information. If you have any questions regarding previously published content, please contact